Low prognostic nutritional index is independently associated with poorer survival in patients receiving immune checkpoint inhibitors

被引：0
作者：
Guven, D. C. [1 ]
Aktepe, O. H. [1 ]
Taban, H. [1 ]
Aktas, B. Y. [1 ]
Guner, G. [1 ]
Yildirim, H. C. [1 ]
Sahin, T. K. [1 ]
Aksun, M. S. [1 ]
Dizdar, O. [1 ]
Aksoy, S. [1 ]
Erman, M. [1 ]
Yalcin, S. [1 ]
Kilickap, S. [1 ]
机构：
[1] Hacettepe Univ Oncol Hosp, Dept Med Oncol, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.587
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98P
引用
收藏
页码：S1457 / S1457
页数：1
相关论文
共 50 条
  • [31] Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study
    Wu, Mengjing
    Zhu, Yunyun
    Chen, Xiancheng
    Wang, Xinpeng
    Lin, Xinyue
    Yan, Xue
    Mo, Peng
    Ye, Ying
    Zeng, Yanjing
    Yang, Yanyong
    Fu, Zhichao
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (01) : 54 - 63
  • [32] Predictive impact of prognostic nutritional index in patients with cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Xu, Xin-Tian
    Qian, Yu
    Tian, Meng-Xing
    Ding, Chen-Chen
    Guo, Huan
    Tang, Jing
    Pi, Guo-Liang
    Wu, Yuan
    Dai, Zhu
    Jin, Xin
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (06): : 1413 - 1426
  • [33] Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
    Tanaka, Satomi
    Uchino, Junji
    Yokoi, Takashi
    Kijima, Takashi
    Goto, Yasuhiro
    Suga, Yoshifumi
    Katayama, Yuki
    Nakamura, Ryota
    Morimoto, Kenji
    Nakao, Akira
    Hibino, Makoto
    Tani, Nozomi
    Takeda, Takayuki
    Yamaguchi, Hiroyuki
    Tachibana, Yusuke
    Takumi, Chieko
    Hiraoka, Noriya
    Takeshita, Masafumi
    Onoi, Keisuke
    Chihara, Yusuke
    Taniguchi, Ryusuke
    Yamada, Takahiro
    Matsui, Yohei
    Hiranuma, Osamu
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Takayama, Koichi
    [J]. DIAGNOSTICS, 2022, 12 (02)
  • [34] Somatic mutations in genes associated with mismatch repair predict survival in patients with metastatic cancer receiving immune checkpoint inhibitors
    Liu, Yongping
    Chen, Lin
    Zhang, Shenli
    Shu, Yimei
    Qi, Qiufeng
    Zhu, Ming
    Peng, Yun
    Ling, Yang
    [J]. ONCOLOGY LETTERS, 2020, 20 (04)
  • [35] Antibiotics associated with lower survival in hepatocellular cancer patients receiving immune checkpoint inhibitors independent of tumor status Response
    Cheung, Ka Shing
    Lam, Lok Ka
    Leung, Wai K.
    [J]. LIVER CANCER, 2023, 12 (01) : 91 - 92
  • [36] Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors
    Chawla, Neal S.
    Sayegh, Nicolas
    Tripathi, Nishita
    Govindarajan, Ameish
    Zengin, Zeynep B.
    Phillip, Errol J.
    Dizman, Nazli
    Meza, Luis
    Muddasani, Ramya
    Chehrazi-Raffle, Alexander
    Malhotra, Jasnoor
    Hsu, JoAnn
    Agarwal, Neeraj
    Pal, Sumanta K.
    Tripathi, Abhishek
    [J]. CLINICAL GENITOURINARY CANCER, 2023, 21 (01) : 69 - 75
  • [37] Novel evidence for the prognostic impact of β-blockers in solid cancer patients receiving immune checkpoint inhibitors
    Yan, Xuebing
    Liu, Peipei
    Li, Donglin
    Hu, Ru
    Tao, Mingyang
    Zhu, Siyuan
    Wu, Wenjuan
    Yang, Mengxue
    Qu, Xiao
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [38] Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors
    Chen, Ning
    Yu, Ying
    Shen, Wanji
    Xu, Xiaoling
    Fan, Yun
    [J]. CLINICAL NUTRITION, 2024, 43 (01) : 142 - 153
  • [39] Association of the Lung Immune Prognostic Index (LIPI) with Outcomes for Immune Checkpoint Inhibitors in Diffuse SCLC Patients
    Mezquita, L.
    Aix, S. Ponce
    Auclin, E.
    Navarro, A.
    Planchard, D.
    Sullivan, I.
    Zalcman, G.
    Mazieres, J.
    Hendriks, L.
    Caramella, C.
    Majem, M.
    Lavaud, P.
    Nana, F. Aboubakar
    Felip, E.
    Paz-Ares, L.
    Besse, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S973 - S974
  • [40] HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors
    Watanabe, Mayu
    Eguchi, Jun
    Takamoto, Atsushi
    Kanzaki, Hiromitsu
    Noda, Yohei
    Kagawa, Syunsuke
    Wada, Jun
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345